Peak6 Investments LLC Akero Therapeutics, Inc. Transaction History
Peak6 Investments LLC
- $43.5 Billion
- Q3 2024
A detailed history of Peak6 Investments LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 7,700 shares of AKRO stock, worth $345,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,700Holding current value
$345,114% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$331 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$307 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$270 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$250 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.08B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...